Home > Financial Ratios > GLAND PHARMA
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 21.6824.8716.1331.1828.05

What is the latest EV/EBIT ratio of GLAND PHARMA ?

The latest EV/EBIT ratio of GLAND PHARMA is 21.68 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202521.68
Mar202424.87
Mar202316.13
Mar202231.18
Mar202128.05

How is EV/EBIT of GLAND PHARMA Trending?

Years EV/EBIT % Change
Mar2025 21.68
-12.83
Mar2024 24.87
54.18
Mar2023 16.13
-48.27
Mar2022 31.18
11.16
Mar2021 28.05 -

Other Financial Ratios of GLAND PHARMA


Compare EV/EBIT ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹40,991.8 Cr -1.1% 11.8% 31.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹470,786.0 Cr 0.8% 7.3% 15.6% Stock Analytics
DIVIS LABORATORIES ₹194,590.0 Cr 1.9% 8.2% 6.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,658.0 Cr 0.6% 12.6% 43.9% Stock Analytics
CIPLA ₹115,728.0 Cr 0.2% 6.3% -4.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,708.0 Cr -1.8% -3.5% -3.4% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-1.1%

11.8%

31.8%

SENSEX

0.5%

0.1%

-6.1%


You may also like the below Video Courses